Filing Details

Accession Number:
0000005768-11-000044
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-13 13:00:13
Reporting Period:
2011-05-12
Filing Date:
2011-05-13
Accepted Time:
2011-05-13 13:00:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
5768 American Science & Engineering Inc. ASEI X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) 042240991
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1353373 Kenneth Breur American Science And Engineering, Inc.
829 Middlesex Turnpike
Billerica MA 01821
Svp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-05-12 1,712 $85.98 4,969 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. On June 12, 2008, the reporting person was granted a restricted stock award for 2,615 shares of common stock. The award vests based on satisfaction of certain performance criteria within a five year period from date of grant. The performance criteria was met for all of the shares, resulting in vesting of the award as to 2,615 shares. On May 15, 2009, the reporting person was granted a restricted stock award for 4,400 shares of common stock. The award vests based on satisfaction of certain performance criteria within a five year period from date of grant. The performance criteria was met as to two thirds of the shares, resulting in vesting of the award as to 2,933 shares.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from a low of $85.74 to a high of $86.48 for an average of $85.98. The reporting person undertakes to provide to American Science and Engineering, Inc., any security holder of American Science and Engineering, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.